{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Cannabinoid", "Caryophyllene", "Inflammation", "Microglia", "PPAR-\u03b3", "Sphingomyelinase"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "30620895", "DateCompleted": {"Year": "2019", "Month": "02", "Day": "25"}, "DateRevised": {"Year": "2019", "Month": "12", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2019", "Month": "01", "Day": "05"}], "Language": ["eng"], "ELocationID": ["10.1016/j.lfs.2018.12.059", "S0024-3205(18)30861-0"], "Journal": {"ISSN": "1879-0631", "JournalIssue": {"Volume": "219", "PubDate": {"Year": "2019", "Month": "Feb", "Day": "15"}}, "Title": "Life sciences", "ISOAbbreviation": "Life Sci"}, "ArticleTitle": "The protective effects of \u03b2-caryophyllene on LPS-induced primary microglia M<sub>1</sub>/M<sub>2</sub> imbalance: A mechanistic evaluation.", "Pagination": {"StartPage": "40", "EndPage": "73", "MedlinePgn": "40-73"}, "Abstract": {"AbstractText": ["Neuroinflammation is observed as a routine characterization of neurodegenerative disorders such as dementia, multiple sclerosis (MS) and Alzheimer's diseases (AD). Scientific evidence propounds both of the neuromodulatory and immunomodulatory effects of CB<sub>2</sub> in the immune system. \u03b2-Caryophyllene (BCP) is a dietary selective CB<sub>2</sub> agonist, which deserves the anti-inflammatory and antioxidant effects at both low and high doses through activation of the CB<sub>2</sub> receptor.", "In this study, we investigated the protective effects of a broad range concentration of BCP against LPS-induced primary microglia cells inflammation and M<sub>1</sub>/M<sub>2</sub> imbalance and identifying the portion of the involvement of related signaling pathways on BCP effects using pharmacological antagonists of CB<sub>2</sub>, PPAR-\u03b3, and sphingomyelinase (SMase).", "The protective effects of BCP on LPS-induced microglia imbalance is provided by the M<sub>2</sub> healing phenotype of microglia, releasing the anti-inflammatory (IL-10, Arg-1, and urea) and anti-oxidant (GSH) parameters and reducing the inflammatory (IL-1\u03b2, TNF-\u03b1, PGE<sub>2</sub>, iNOS and NO) and oxidative (ROS) biomarkers. Moreover, we showed that BCP exerts its effects through CB<sub>2</sub> receptors which overproduction of ceramides by SMase at middle to higher concentrations of BCP reduce the protective activity of BCP and results in the activation of the PPAR-\u03b3 pathway.", "In conclusion, the low concentration of BCP has higher selective anti-inflammatory effects rather than high levels. On this occasion, BCP by modulating the microglia is able to have potential therapeutic effects in neuro-inflammation conditions and microglia cells such as MS and AD."], "CopyrightInformation": "Copyright \u00a9 2019 Elsevier Inc. All rights reserved."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: askariv941@mums.ac.ir."}], "LastName": "Askari", "ForeName": "Vahid Reza", "Initials": "VR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmacological Research Center of Medicinal Plants, Mashhad University of Medical Sciences, Mashhad, Iran; Student Research Committee, Department of Pharmacology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran. Electronic address: Shafieer@mums.ac.ir."}], "LastName": "Shafiee-Nick", "ForeName": "Reza", "Initials": "R"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Netherlands", "MedlineTA": "Life Sci", "NlmUniqueID": "0375521", "ISSNLinking": "0024-3205"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antioxidants"}, {"RegistryNumber": "0", "NameOfSubstance": "Cytokines"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "0", "NameOfSubstance": "Neuroprotective Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Polycyclic Sesquiterpenes"}, {"RegistryNumber": "0", "NameOfSubstance": "Reactive Oxygen Species"}, {"RegistryNumber": "0", "NameOfSubstance": "Sesquiterpenes"}, {"RegistryNumber": "31C4KY9ESH", "NameOfSubstance": "Nitric Oxide"}, {"RegistryNumber": "8W8T17847W", "NameOfSubstance": "Urea"}, {"RegistryNumber": "BHW853AU9H", "NameOfSubstance": "caryophyllene"}, {"RegistryNumber": "EC 1.14.13.39", "NameOfSubstance": "Nitric Oxide Synthase Type II"}, {"RegistryNumber": "EC 3.5.3.1", "NameOfSubstance": "Arg1 protein, mouse"}, {"RegistryNumber": "EC 3.5.3.1", "NameOfSubstance": "Arginase"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Antioxidants"}, {"QualifierName": ["metabolism"], "DescriptorName": "Arginase"}, {"QualifierName": [], "DescriptorName": "Cells, Cultured"}, {"QualifierName": ["metabolism"], "DescriptorName": "Cytokines"}, {"QualifierName": ["chemically induced", "drug therapy"], "DescriptorName": "Inflammation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred C57BL"}, {"QualifierName": ["drug effects"], "DescriptorName": "Microglia"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Neuroprotective Agents"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide"}, {"QualifierName": ["metabolism"], "DescriptorName": "Nitric Oxide Synthase Type II"}, {"QualifierName": [], "DescriptorName": "Polycyclic Sesquiterpenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Reactive Oxygen Species"}, {"QualifierName": ["pharmacology", "therapeutic use"], "DescriptorName": "Sesquiterpenes"}, {"QualifierName": ["metabolism"], "DescriptorName": "Urea"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "2018", "Month": "11", "Day": "16"}, {"Year": "2018", "Month": "12", "Day": "6"}, {"Year": "2018", "Month": "12", "Day": "31"}, {"Year": "2019", "Month": "1", "Day": "9", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "2", "Day": "26", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "9", "Hour": "6", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["30620895", "10.1016/j.lfs.2018.12.059", "S0024-3205(18)30861-0"]}}]}